Logo image of CHR.CA

CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:CHR - CA17040T8885 - Common Stock

21.56 CAD
-0.04 (-0.19%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CHR. CHR was compared to 5 industry peers in the Passenger Airlines industry. CHR has an average financial health and profitability rating. CHR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CHR was profitable.
CHR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
Each year in the past 5 years CHR had a positive operating cash flow.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CHR's Return On Assets of -2.62% is on the low side compared to the rest of the industry. CHR is outperformed by 60.00% of its industry peers.
CHR has a Return On Equity of -6.31%. This is in the better half of the industry: CHR outperforms 80.00% of its industry peers.
CHR has a Return On Invested Capital of 6.40%. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 3.84%.
The 3 year average ROIC (5.30%) for CHR is below the current ROIC(6.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROIC 6.4%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

CHR has a Operating Margin of 6.81%. This is in the better half of the industry: CHR outperforms 80.00% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
CHR's Gross Margin of 65.68% is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
Industry RankSector Rank
OM 6.81%
PM (TTM) N/A
GM 65.68%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHR is destroying value.
The number of shares outstanding for CHR has been reduced compared to 1 year ago.
Compared to 5 years ago, CHR has more shares outstanding
The debt/assets ratio for CHR has been reduced compared to a year ago.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.90, we must say that CHR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.90, CHR perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
The Debt to FCF ratio of CHR is 10.63, which is on the high side as it means it would take CHR, 10.63 years of fcf income to pay off all of its debts.
CHR's Debt to FCF ratio of 10.63 is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that CHR is somewhat dependend on debt financing.
CHR has a Debt to Equity ratio of 0.50. This is in the better half of the industry: CHR outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Altman-Z 0.9
ROIC/WACC0.79
WACC8.11%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CHR has a Current Ratio of 1.22. This is a normal value and indicates that CHR is financially healthy and should not expect problems in meeting its short term obligations.
CHR has a Current ratio of 1.22. This is comparable to the rest of the industry: CHR outperforms 60.00% of its industry peers.
CHR has a Quick Ratio of 1.22. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CHR (0.63) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.63
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 92.86% over the past year.
Measured over the past years, CHR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.03% on average per year.
The Revenue has decreased by -8.40% in the past year.
The Revenue has been growing slightly by 0.56% on average over the past years.
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%

3.2 Future

Based on estimates for the next years, CHR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.19% on average per year.
Based on estimates for the next years, CHR will show a decrease in Revenue. The Revenue will decrease by -4.52% on average per year.
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.87, the valuation of CHR can be described as reasonable.
CHR's Price/Earnings ratio is rather cheap when compared to the industry. CHR is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.19, CHR is valued rather cheaply.
A Price/Forward Earnings ratio of 10.97 indicates a reasonable valuation of CHR.
Based on the Price/Forward Earnings ratio, CHR is valued a bit cheaper than 80.00% of the companies in the same industry.
CHR is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.87
Fwd PE 10.97
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR is valued a bit cheaper than 80.00% of the companies in the same industry.
CHR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 15.54
EV/EBITDA 3.91
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CHR's earnings are expected to grow with 14.19% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y14.11%
EPS Next 3Y14.19%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.48%, CHR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.92, CHR pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 1.90, CHR is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.48%

5.2 History

On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 1 2 3

5.3 Sustainability

CHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-5.89%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR (1/9/2026, 7:00:00 PM)

21.56

-0.04 (-0.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners1.28%
Ins Owner ChangeN/A
Market Cap504.94M
Revenue(TTM)1.35B
Net Income(TTM)-34.96M
Analysts78.18
Price Target30.26 (40.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.48%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)5.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.14%
EPS NY rev (1m)0%
EPS NY rev (3m)4.22%
Revenue NQ rev (1m)-2.01%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.68%
Valuation
Industry RankSector Rank
PE 8.87
Fwd PE 10.97
P/S 0.37
P/FCF 15.54
P/OCF 7.09
P/B 0.91
P/tB 0.93
EV/EBITDA 3.91
EPS(TTM)2.43
EY11.27%
EPS(NY)1.97
Fwd EY9.12%
FCF(TTM)1.39
FCFY6.44%
OCF(TTM)3.04
OCFY14.1%
SpS57.62
BVpS23.67
TBVpS23.29
PEG (NY)0.14
PEG (5Y)N/A
Graham Number35.98
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROCE 8.63%
ROIC 6.4%
ROICexc 6.56%
ROICexgc 6.62%
OM 6.81%
PM (TTM) N/A
GM 65.68%
FCFM 2.41%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Debt/EBITDA 1.32
Cap/Depr 32.58%
Cap/Sales 2.87%
Interest Coverage 2.74
Cash Conversion 33.79%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.63
Altman-Z 0.9
F-Score6
WACC8.11%
ROIC/WACC0.79
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year87.77%
EBIT Next 3Y14.37%
EBIT Next 5YN/A
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHR.CA.


Can you provide the valuation status for CHORUS AVIATION INC?

ChartMill assigns a valuation rating of 6 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for CHR stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 8.87 and the Price/Book (PB) ratio is 0.91.


How financially healthy is CHORUS AVIATION INC?

The financial health rating of CHORUS AVIATION INC (CHR.CA) is 4 / 10.